Kohan Ventures
United States
Mr. Lavigne served as Board Member at Puppet and BMC Software. Mr. Lavigne serves as a Director at DocuSign. He is managing director of Lavrite, LLC and former Executive Vice President and Chief Financial Officer of Genentech Inc., leads DocuSign's Audit and Finance Committee. He brings decades of corporate finance, accounting, growth strategy and IT management experience to DocuSign's board. In his twenty-three years at Genentech, he led the company's financial, corporate relations and information technology groups as revenues grew from $40 million in 1983 to $300 million in 1988 when he became CFO to more than $6.5 billion in 2005 when he was named 'Best CFO in Biotech' by Institutional Investor. Mr. Lavigne is a Chairman and Member of the Board of Directors of Accuray, Inc. (Chairman of the Board & Compensation Committee), Allergan, Inc. (Member of the Audit and Finance & Science and Technology Committees), BMC Software (Chairman of the Audit Committee & Member of the M&A Committee), Depomed, Inc. (Audit Committee member), NovoCure (Audit Committee Chairman) and SafeNet, Inc. (Audit Committee Chairman). Previously, he was a Director and Chairman of the Audit Committee of several other public companies including Arena Pharmaceuticals, Equinix, Kyphon and Genova. Mr. Lavigne is also part of the Pacific SW Audit Committee Network of Audit Committee Chairs and Deloitte's Life Sciences Advisory Board. Mr. Lavigne is the managing member of Spring Development Group, LLC, a strategic investor in companies with unique growth opportunities. Mr. Lavigne is a board member and former Chairman of the UCSF Benioff Children's Hospitals. Mr. Lavigne is also a member of the West Coast Audit Committee Network and the faculty of the GLG Institute. He also served as Chairman of the Children's Hospital & Research Center Foundation. He serves as Board Member at Zynga.
Individual/Angel